IMDXHealthcareMicro-Cap

Insight Molecular Diagnostics Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Insight Molecular Diagnostics Inc. (IMDX), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are IMDX insiders buying or selling?

Insight Molecular Diagnostics Inc. insiders reported 66 open-market buys ($128.6M) and 7 sells ($16.4M) across 73 Form 4 filings — a net buying position of $112.2M.

Source: SEC EDGAR Form 4

Key Statistics (as of Apr 27, 2026)

Total Form 4 filings
73
SEC EDGAR
Insider filers
21
Insider buys (66)
$128.6M
Insider sells (7)
$16.4M

Insider sentiment

Net buying

Net insider flow of $112.2M in net buying. 1 insider buy in the last 90 days.

Recent IMDX insider transactions

DateInsiderRoleTypeSharesPriceValue
Apr 27, 2026Neal C Bradsher10% OwnerPurchase570.2K$3.56$2.0M
Apr 20, 2026Neal C Bradsher10% OwnerPurchase182.9K$3.57$652.9K
Feb 13, 2026Neal C Bradsher10% OwnerPurchase521.7K$5.75$3.0M
Feb 12, 2025Andrea S. JamesChief Financial OfficerPurchase97.6K$2.05$200.0K
Feb 11, 2025SMITH PATRICK W10% OwnerPurchase1.1M$2.05$2.2M
Feb 11, 2025Neal C Bradsher10% OwnerPurchase5.2M$2.05$10.6M
Feb 4, 2025SMITH PATRICK W10% OwnerPurchase915$2.01$1.8K
Jan 31, 2025SMITH PATRICK W10% OwnerPurchase4.2K$2.01$8.4K
Jan 15, 2025SMITH PATRICK W10% OwnerPurchase16.1K$2.12$34.1K
Dec 28, 2024SMITH PATRICK W10% OwnerPurchase90.2K$2.13$192.2K
Dec 26, 2024Arno AndrewDirectorPurchase12.5K$2.11$26.4K
Dec 9, 2024Andrea S. JamesChief Financial OfficerPurchase20.0K$2.29$45.8K
Oct 4, 2024Andrea S. JamesChief Financial OfficerPurchase33.7K$2.97$100.0K
Oct 4, 2024Neal C Bradsher10% OwnerPurchase1.3M$2.95$3.9M
Apr 15, 2024Neal C Bradsher10% OwnerPurchase2.4M$2.92$7.1M
Apr 15, 2024Josh RiggsCEO and PresidentPurchase3.4K$2.95$10.0K
Apr 15, 2024Arno AndrewDirectorPurchase33.9K$2.95$100.0K
Jun 16, 2023Alfred D KingsleyDirectorPurchase30.0K$0.21$6.4K
Apr 7, 2023PURA VIDA INVESTMENTS, LLC10% OwnerPurchase663.0K$0.30$200.0K
Apr 6, 2023Neal C Bradsher10% OwnerPurchase26.8M$0.30$8.1M
Dec 28, 2022Arno AndrewDirectorPurchase250.0K$0.35$87.9K
Dec 28, 2022John Peter GutfreundDirectorPurchase75.0K$0.33$24.7K
Dec 27, 2022Alfred D KingsleyDirectorPurchase25.0K$0.29$7.1K
Aug 19, 2022Andrew J. LastDirectorPurchase20.0K$0.87$17.4K
Aug 19, 2022Arno AndrewDirectorPurchase15.0K$0.90$13.5K

Showing the 25 most recent of 73 Form 4 filings for Insight Molecular Diagnostics Inc..

Most active IMDX insiders

  • Neal C Bradsher16 filings
  • Arno Andrew7 filings
  • Ronald Asbury Andrews7 filings
  • Levine Mitchell S6 filings
  • Alfred D Kingsley5 filings

Ask anything about IMDX insider activity

Use Trabud's AI agent to query Insight Molecular Diagnostics Inc.'s Form 4 history in plain English — "Show me IMDX CEO purchases this year" or compare it against any other ticker.

Open the AI agent

IMDX insider trading FAQ

Are Insight Molecular Diagnostics Inc. insiders buying or selling?

Across 73 SEC Form 4 filings, Insight Molecular Diagnostics Inc. (IMDX) insiders reported 66 open-market purchases totaling $128.6M and 7 sales totaling $16.4M. That is a net buying position of $112.2M.

How many insiders trade IMDX stock?

21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Insight Molecular Diagnostics Inc.. The most recent filing was accepted on Apr 27, 2026.

Where does Trabud get IMDX insider trading data?

All IMDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content